People · Operator
Named in public records as an officer, director or promoter · active 2009–2019 · Other Health Care, Pharmaceuticals, Healthtech, Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Vertiflex, Inc. | — | Other Health Care | Series C | $134.1M | $1.0B | 2009 |
| Talphera, Inc. | — | Pharmaceuticals | Series B | $97.4M | $74.1M | 2010 |
| Usgi Medical Inc | — | Healthtech | Series B | $33.9M | $59.5M | 2012 |
| Spiral Therapeutics Inc | — | Pharma | Series A | $19.4M | $120.5M | 2018 |
| Carbylan Therapeutics, Inc. | — | Other Health Care | Series A | $15.0M | $80.7M | 2012 |
Guy Nohra at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Guy Nohra on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Guy P. Nohra | 3 | 3 |
| Mark Wan | 1 | 10 |
| Albert Cha | 1 | 9 |
| Martin J. Waters | 1 | 9 |
| Stephen Hoffman | 1 | 7 |
| Peter Justin Klein | 1 | 7 |
| Paul Klingenstein | 1 | 6 |
| Chris Ehrlich | 1 | 6 |
| Howard Rosen | 1 | 5 |
| Peter Klein | 1 | 5 |
| Mark Edwards | 1 | 4 |
| Mark Weeks | 1 | 4 |
| Howard B. Rosen | 1 | 4 |
| James Welch | 1 | 4 |
| Carlos Babini | 1 | 3 |
| James H. Welch | 1 | 3 |
| John Cox | 1 | 3 |
| Scott Moonly | 1 | 3 |
| William Mavity | 1 | 3 |
| Richard King | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.